These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37132338)

  • 1. Glycated albumin and risk of cardiovascular diseases and mortality in patients with and without dialysis: A meta-analysis.
    Zhao H; Hu Q; Chen J; Ling Q; Yan Z; Yu P; Zhang J; Liu X
    Diabetes Obes Metab; 2023 Aug; 25(8):2203-2217. PubMed ID: 37132338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association.
    Hoshino J; Abe M; Hamano T; Hasegawa T; Wada A; Nakai S; Hanafusa N; Masakane I; Nitta K
    Nephrol Dial Transplant; 2023 May; 38(5):1309-1317. PubMed ID: 36309475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal aortic calcification can predict all-cause mortality and CV events in dialysis patients: A systematic review and meta-analysis.
    Niu Q; Hong Y; Lee CH; Men C; Zhao H; Zuo L
    PLoS One; 2018; 13(9):e0204526. PubMed ID: 30240443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis.
    Murea M; Moran T; Russell GB; Shihabi ZK; Byers JR; Andries L; Bleyer AJ; Freedman BI
    Am J Nephrol; 2012; 36(5):488-96. PubMed ID: 23147746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Glycated Albumin in Serum Is Associated with Adverse Cardiac Outcomes in Patients with Acute Coronary Syndrome Who Underwent Revascularization Therapy.
    Zhang J; Du Y; Hu C; Liu Y; Liu J; Gao A; Zhao Y; Zhou Y
    J Atheroscler Thromb; 2022 Apr; 29(4):482-491. PubMed ID: 33642440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients' conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study.
    Hoshino J; Abe M; Hamano T; Hasegawa T; Wada A; Ubara Y; Takaichi K; Nakai S; Masakane I; Nitta K
    BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33099507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis.
    Liu X; Tan Z; Huang Y; Zhao H; Liu M; Yu P; Ma J; Zhao Y; Zhu W; Wang J
    Cardiovasc Diabetol; 2022 Jul; 21(1):124. PubMed ID: 35778731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
    Marsico F; Paolillo S; Gargiulo P; Bruzzese D; Dell'Aversana S; Esposito I; Renga F; Esposito L; Marciano C; Dellegrottaglie S; Iesu I; Perrone Filardi P
    Eur Heart J; 2020 Sep; 41(35):3346-3358. PubMed ID: 32077924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study.
    Chan M; Kelly J; Batterham M; Tapsell L
    J Ren Nutr; 2012 Nov; 22(6):547-57. PubMed ID: 22406122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 levels can be used to estimate cardiovascular and all-cause mortality risk in dialysis patients: A meta-analysis and a systematic review.
    Chen Z; Wang Y
    Immun Inflamm Dis; 2023 Apr; 11(4):e818. PubMed ID: 37102647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease.
    Norimatsu K; Miura S; Suematsu Y; Shiga Y; Miyase Y; Nakamura A; Yamada M; Matsunaga A; Saku K
    J Cardiol; 2015 Jun; 65(6):487-93. PubMed ID: 25107604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
    Shafi T; Sozio SM; Plantinga LC; Jaar BG; Kim ET; Parekh RS; Steffes MW; Powe NR; Coresh J; Selvin E
    Diabetes Care; 2013 Jun; 36(6):1522-33. PubMed ID: 23250799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies.
    Zhang Y; Darssan D; Pascoe EM; Johnson DW; Pi H; Dong J
    Nephrol Dial Transplant; 2018 Oct; 33(10):1742-1751. PubMed ID: 29481620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.
    Okada T; Nakao T; Matsumoto H; Shino T; Nagaoka Y; Tomaru R; Wada T
    Intern Med; 2007; 46(12):807-14. PubMed ID: 17575371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.